Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

L-Serine-S2-PEG-Formic acid

L-Serine-S2-PEG-Formic acid is a linker for FGT-4. FGT-4, a TLR7 agonist, is a folate receptor β (FR-β) targeting chimeric molecule[1].

Product Specifications

UNSPSC

12352211

Target

Others

Related Pathways

Others

Field of Research

Cancer

Smiles

O=C(O)OCCSSC[C@H](N)C(O)=O

Molecular Formula

C6H11NO5S2

Molecular Weight

241.29

References & Citations

[1]Lixiao Guo, Design and Synthesis of FR-β Targeting Chimeric Molecules for Reprogramming Tumor-Associated Macrophages Using 6-Substituted Pyrrolo[2,3- d]pyrimidines as Targeting Ligands. J Med Chem. 2025 Apr 24;68 (8) :8295-8309.

Shipping Conditions

Room temperature

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

6-[ (3S,8S,9S,10R,13S,14S,17S) -3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxo-1H-pyridine-3,4-dicarbonitrile
BUP12208-01 1 mg

6-[ (3S,8S,9S,10R,13S,14S,17S) -3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxo-1H-pyridine-3,4-dicarbonitrile

Sign In for Pricing
View Details
6-[ (3S,8S,9S,10R,13S,14S,17S) -3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxo-1H-pyridine-3,4-dicarbonitrile
BUP12208-02 5 mg

6-[ (3S,8S,9S,10R,13S,14S,17S) -3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxo-1H-pyridine-3,4-dicarbonitrile

Sign In for Pricing
View Details
6-[ (3S,8S,9S,10R,13S,14S,17S) -3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxo-1H-pyridine-3,4-dicarbonitrile
BUP12208-03 10 mg

6-[ (3S,8S,9S,10R,13S,14S,17S) -3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxo-1H-pyridine-3,4-dicarbonitrile

Sign In for Pricing
View Details
6-[ (3S,8S,9S,10R,13S,14S,17S) -3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxo-1H-pyridine-3,4-dicarbonitrile
BUP12208-04 25 mg

6-[ (3S,8S,9S,10R,13S,14S,17S) -3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxo-1H-pyridine-3,4-dicarbonitrile

Sign In for Pricing
View Details
6-[ (3S,8S,9S,10R,13S,14S,17S) -3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxo-1H-pyridine-3,4-dicarbonitrile
BUP12208-05 50 mg

6-[ (3S,8S,9S,10R,13S,14S,17S) -3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxo-1H-pyridine-3,4-dicarbonitrile

Sign In for Pricing
View Details
6-[ (3S,8S,9S,10R,13S,14S,17S) -3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxo-1H-pyridine-3,4-dicarbonitrile
BUP12208-06 100 mg

6-[ (3S,8S,9S,10R,13S,14S,17S) -3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxo-1H-pyridine-3,4-dicarbonitrile

Sign In for Pricing
View Details